- Mortality Risk Scoring System in Patients after Bleeding from Cancers in the Upper Gastrointestinal Tract
-
Kim HM, Kang D, Park JY, Cho YK, Choi MG, Park JM
- KMID: 2553831
- Gut Liver.
- 2024 Mar;18(2):222-230.
- doi: 10.5009/gnl230069
Background/Aims: Risk scoring systems for upper gastrointestinal (UGI) bleeding have not been well validated for tumor bleeding. This study aimed to identify risk factors for mortality in patients with UGI... -
- CITED
-
- Close
- SHARE
-
- Close
- Development Study of a Predictive Model for the Possibility of Collection Delinquent Health Insurance Contributions
-
Na YK
- KMID: 2551400
- Health Policy Manag.
- 2023 Dec;33(4):450-456.
- doi: 10.4332/KJHPA.2023.33.4.450
Background: This study aims to develop a “Predictive Model for the Possibility of Collection Delinquent Health Insurance Contributions” for the National Health Insurance Service to enhance administrative efficiency in protecting... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of High- and Low-Dose Rivaroxaban Regimens in Elderly East Asian Patients With Atrial Fibrillation
-
Kim JY, Kim J, Park SJ, Park KM, Kim JS, Kim SH, Shim J, Choi EK, Kim DH, Oh IY, On YK, on behalf of the XAIENT Study Group
- KMID: 2553325
- J Korean Med Sci.
- 2024 Mar;39(8):e72.
- doi: 10.3346/jkms.2024.39.e72
Background: In the Rivaroxaban Once-daily oral direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) trial, rivaroxaban 20... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world effectiveness of a single conventional diseasemodifying anti-rheumatic drug (cDMARD) plus an anti-TNF agent versus multiple cDMARDs in rheumatoid arthritis: a prospective observational study
-
So MW, Kim SH, Kim DW, Sung YK, Choe JY, Lee SI, Hur JW, Lee HS, Lee SH, Kim JR
- KMID: 2554324
- J Rheum Dis.
- 2024 Apr;31(2):86-96.
- doi: 10.4078/jrd.2023.0045
Objective: The objective of this prospective, observational multicenter study (NCT03264703) was to compare the effectiveness of single conventional disease-modifying anti-rheumatic drug (cDMARD) plus anti-tumor necrosis factor (TNF) therapy versus multiple... -
- CITED
-
- Close
- SHARE
-
- Close
